Blood Banking in Europe: Market Segment Forecasts and Supplier Shares

March 2013 | 600 pages | ID: B04E31926F4EN
Venture Planning Group

Abstracts

This unique report provides information not available from any other published source, including volume, sales, and leading supplier shares by test.

This comprehensive five-country report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the European blood banking market during the next five years, and to assist industry executives in developing effective business, new product development and marketing strategies.

The report explores future marketing and technological trends in France, Germany, Italy, Spain and the UK; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years.

During the next five years, the blood banking market will undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology.

The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications.

Contains 600 pages and 170 tables

Contents

WORLDWIDE TECHNOLOGY AND MARKET OVERVIEW

A. MAJOR BLOOD TYPING, GROUPING AND INFECTIOUS

DISEASE SCREENING TESTS

1. Blood Typing and Grouping Tests
  a. ABO
  b. Antibody Panels
  c. Antibody Screening
  d. Antigen Typing
  e. Antiglobulin Test
  f. Crossmatch
  g. HLA Typing
  h. Rh
  i. Other Blood Groups
2. Infectious Disease Screening Tests
  a. AIDS
    Structure and Composition
    Classification
    Origin of AIDS
    Animal Lentivirus Systems
    Virus Receptors
    HIV Infections in Humans
      Pathogenesis & Pathology
      Overview of Course of HIV Infection
    CD4T Lymphocytes and Memory Cells
    Monocytes and Macrophages
    Lymphoid Organs
    Neural Cells
    Viral Coinfections
      Clinical Findings
    Plasma Viral Load
    Pediactric AIDS
      Neurologic Disease
      Opportunistic Infections
      Protozoa
      Fungi
      Bacteria
    Viruses
    Cancer
    Immunity
    Laboratory Diagnosis
      Virus Isolation
      Serology
      Detection of Viral Nucleic Acid or Antigens
    Epidemiology
      Worldwide Spread of AIDS
      United States
      Routes of Transmission
    Prevention, Treatment, And Control
      Antiviral Drugs
      Vaccines Against HIV
    Transmission of HIV in Blood Products
    HIV Transmission in Transplant and Artificial Insemination Recipients
    Diagnostic Tests
    Enzyme Immunoassay Interpretation
    Specificity, Sensitivity, and Predictive Value of Enzyme Immunoassay
    Competition Assays
    Western Blot Technique
    Immuno-Fluorescence Assay (IFA)
    Radioimmunoprecipitation
    HIV-1/HIV-2 Combination Testing
    Methods of HIV-Antigen Detection
    Antigen Assays and Blood Screening
    Urine Tests
    DNA Probes
    Overview
    Quantitative Polymerase Chain Reaction
    In Situ PCR
    Needed Improvements
    Viral Load/Drug Resistance Testing
    Genotype and Phenotype Testing
    Blood Banking Considerations
  b. Hepatitis
    Hepatitis A
    Hepatitis B
      Structure and Composition
      Replication of Hepatitis B Virus